BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 18799290)

  • 1. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
    Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
    Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
    Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
    Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and structural correlates of executive dysfunction in schizophrenia.
    Rüsch N; Tebartz van Elst L; Valerius G; Büchert M; Thiel T; Ebert D; Hennig J; Olbrich HM
    Schizophr Res; 2008 Feb; 99(1-3):155-63. PubMed ID: 17616347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
    Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Anterior Cingulate N-Acetylaspartate and Executive Functioning in Treatment-Resistant Depression After rTMS Therapy.
    Zheng H; Jia F; Guo G; Quan D; Li G; Wu H; Zhang B; Fan C; He X; Huang H
    Int J Neuropsychopharmacol; 2015 May; 18(11):pyv059. PubMed ID: 26025780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of executive functioning deficits to N-acetyl aspartate (NAA) and gamma-aminobutyric acid (GABA) in youth with bipolar disorder.
    Huber RS; Kondo DG; Shi XF; Prescot AP; Clark E; Renshaw PF; Yurgelun-Todd DA
    J Affect Disord; 2018 Jan; 225():71-78. PubMed ID: 28800423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia.
    Rüsch N; Spoletini I; Wilke M; Bria P; Di Paola M; Di Iulio F; Martinotti G; Caltagirone C; Spalletta G
    Schizophr Res; 2007 Jul; 93(1-3):79-89. PubMed ID: 17383859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users.
    Hermann D; Sartorius A; Welzel H; Walter S; Skopp G; Ende G; Mann K
    Biol Psychiatry; 2007 Jun; 61(11):1281-9. PubMed ID: 17239356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo (1)H-MRS study of the Stroop Color-Word task.
    Grachev ID; Kumar R; Ramachandran TS; Szeverenyi NM
    Mol Psychiatry; 2001 Sep; 6(5):496, 529-39. PubMed ID: 11526467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study.
    Shirayama Y; Obata T; Matsuzawa D; Nonaka H; Kanazawa Y; Yoshitome E; Ikehira H; Hashimoto K; Iyo M
    Neuroimage; 2010 Feb; 49(3):2783-90. PubMed ID: 19850131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia.
    Braus DF; Ende G; Weber-Fahr W; Demirakca T; Tost H; Henn FA
    Eur Neuropsychopharmacol; 2002 Apr; 12(2):145-52. PubMed ID: 11872332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients.
    Huang ML; Khoh TT; Lu SJ; Pan F; Chen JK; Hu JB; Hu SH; Xu WJ; Zhou WH; Wei N; Qi HL; Shang DS; Xu Y
    Medicine (Baltimore); 2017 Jun; 96(25):e7228. PubMed ID: 28640119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypo-metabolism of the rostral anterior cingulate cortex associated with working memory impairment in 18 cases of schizophrenia.
    Mazgaj R; Tal A; Goetz R; Lazar M; Rothman K; Messinger JW; Malaspina D; Gonen O
    Brain Imaging Behav; 2016 Mar; 10(1):115-23. PubMed ID: 25804309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D; Ozdel O; Sözeri-Varma G; Kıroğlu Y; Tümkaya S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):176-81. PubMed ID: 22306485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia.
    Callicott JH; Bertolino A; Egan MF; Mattay VS; Langheim FJ; Weinberger DR
    Am J Psychiatry; 2000 Oct; 157(10):1646-51. PubMed ID: 11007719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.